Current Pharmaceutical Design
Title:Editorial: Recent Advances in the Field of Kinases and Kinase Inhibitors
Volume: 23 Issue: 29
Author(s): Zunnan Huang and Mee-Hyun Lee
Affiliation:
Export Options
About this article
Cite this article as:
Huang Zunnan and Lee Mee-Hyun , Editorial: Recent Advances in the Field of Kinases and Kinase Inhibitors, Current Pharmaceutical Design 2017; 23 (29) . https://dx.doi.org/10.2174/138161282329171116095519
DOI https://dx.doi.org/10.2174/138161282329171116095519 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
57
1
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Editorial
Infectious Disorders - Drug Targets Trypanocidal Activity of Nitroaromatic Prodrugs: Current Treatments and Future Perspectives
Current Topics in Medicinal Chemistry Spontaneous Pneumothorax
Current Respiratory Medicine Reviews Transition-State-Guided Drug Design for Treatment of Parasitic Neglected Tropical Diseases
Current Medicinal Chemistry Occupational Respiratory Pathology in Russia: Current Trends and Challenges
Current Respiratory Medicine Reviews New Tuberculosis Drugs in Development
Current Topics in Medicinal Chemistry Oxidative Stress in HIV Patients Receiving Antiretroviral Therapy
Current HIV Research Nanotechnology for Delivery of Drugs and Biomedical Applications
Current Clinical Pharmacology Nanoemulsion Formulation Enhances Intracellular Activity of Capuramycin Analogues against Mycobacterium Tuberculosis
Drug Delivery Letters High Throughput Screening of 7-Methylpicene-1,2-Diol as Arylamine N-Acetyltransferase (NAT) Inhibitor to Establish a Isoniazid Supplement in Anti-Tubercular Therapy
Combinatorial Chemistry & High Throughput Screening A Technological Update of Molecular Diagnostics for Infectious Diseases
Infectious Disorders - Drug Targets Patent Selections:
Recent Patents on Anti-Infective Drug Discovery Preface
Current Pharmaceutical Design 4H-1,3-Benzothiazin-4-one a Promising Class Against MDR/XDR-TB
Current Topics in Medicinal Chemistry 3D QSAR, Docking, Molecular Dynamics Simulations and MM-GBSA studies of Extended Side Chain of the Antitubercular Drug (6S) 2-Nitro-6- {[4-(trifluoromethoxy) benzyl] oxy}-6,7-dihydro-5H-imidazo[2,1-b] [1,3] oxazine.
Infectious Disorders - Drug Targets Shikimate Kinase: A Potential Target for Development of Novel Antitubercular Agents
Current Drug Targets Target Validation: Linking Target and Chemical Properties to Desired Product Profile
Current Topics in Medicinal Chemistry Synthesis of Novel Aryl (4-Aryl-1H-Pyrrol-3-yl) (Thiophen-2-yl) Methanone Derivatives: Molecular Modelling, In Silico ADMET, Anti-Inflammatory and Anti-Ulcer Activities
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Virus-Associated Vasculitides: An Update
Current Immunology Reviews (Discontinued) Exit from Mycobacterial Dormancy: A Structural Perspective
Current Medicinal Chemistry